Allstate Corp (NYSE:ALL) Shares Bought by Foster & Motley Inc.
Foster & Motley Inc. increased its holdings in Allstate Corp (NYSE:ALL) by 9.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,213 shares of the insurance provider’s stock after purchasing an additional 1,810 shares during the quarter. Foster & Motley Inc.’s holdings in Allstate were worth $2,055,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ALL. Cornerstone Advisors Inc. grew its position in shares of Allstate by 15.3% in the second quarter. Cornerstone Advisors Inc. now owns 800 shares of the insurance provider’s stock valued at $81,000 after purchasing an additional 106 shares in the last quarter. Orrstown Financial Services Inc. grew its position in shares of Allstate by 1.1% in the second quarter. Orrstown Financial Services Inc. now owns 10,417 shares of the insurance provider’s stock valued at $1,059,000 after purchasing an additional 116 shares in the last quarter. First National Trust Co grew its position in shares of Allstate by 5.7% in the first quarter. First National Trust Co now owns 2,626 shares of the insurance provider’s stock valued at $248,000 after purchasing an additional 142 shares in the last quarter. UNIVEST FINANCIAL Corp grew its position in shares of Allstate by 0.3% in the second quarter. UNIVEST FINANCIAL Corp now owns 43,384 shares of the insurance provider’s stock valued at $4,412,000 after purchasing an additional 144 shares in the last quarter. Finally, Manning & Napier Group LLC grew its position in shares of Allstate by 2.0% in the first quarter. Manning & Napier Group LLC now owns 7,245 shares of the insurance provider’s stock valued at $681,000 after purchasing an additional 145 shares in the last quarter. 77.51% of the stock is owned by institutional investors.
In other Allstate news, Director Judith A. Sprieser sold 2,225 shares of the firm’s stock in a transaction on Friday, June 21st. The stock was sold at an average price of $102.63, for a total value of $228,351.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Glenn T. Shapiro sold 22,289 shares of the firm’s stock in a transaction on Tuesday, June 25th. The shares were sold at an average price of $102.22, for a total value of $2,278,381.58. Following the completion of the sale, the insider now owns 25,584 shares in the company, valued at $2,615,196.48. The disclosure for this sale can be found here. Over the last quarter, insiders sold 54,703 shares of company stock worth $5,593,860. Insiders own 1.60% of the company’s stock.
Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, May 1st. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.28 by $0.02. The business had revenue of $8.70 billion for the quarter, compared to analysts’ expectations of $8.82 billion. Allstate had a return on equity of 12.66% and a net margin of 6.26%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period last year, the firm earned $2.96 earnings per share. As a group, analysts expect that Allstate Corp will post 8.64 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date is Thursday, August 29th. Allstate’s payout ratio is currently 24.78%.
ALL has been the subject of a number of analyst reports. Goldman Sachs Group upgraded Koninklijke KPN from a “neutral” rating to a “buy” rating in a research report on Wednesday, May 29th. UBS Group restated a “buy” rating and issued a $25.00 price target on shares of Infineon Technologies in a research report on Tuesday, May 7th. Barclays restated a “buy” rating and issued a $65.00 price target on shares of Owens Corning in a research report on Monday, July 1st. Credit Suisse Group initiated coverage on Merck & Co., Inc. in a research report on Thursday, July 11th. They issued a “buy” rating and a $95.00 price objective for the company. Finally, Morgan Stanley set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research report on Friday, July 19th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $105.42.
The Allstate Corporation, through its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection, Service Businesses, Allstate Life, and Allstate Benefits segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home insurance; and commercial lines products under the Allstate, Esurance, and Encompass brand names.
Recommended Story: What is the price-to-earnings growth (PEG) ratio?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.